カテゴリー： QYResearch, 世界

世界の強皮症の診断および治療市場

◆英語タイトル：Global Scleroderma Diagnostics and Therapeutics Market Professional Survey Report 2019
◆商品コード：DATA909X14767
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、強皮症の診断および治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コルチコステロイド、免疫抑制剤、エンドセリン受容体作動薬、カルシウムチャネル遮断薬、PDE-5阻害剤、キレート剤、プロスタサイクリンアナログ、その他（H2遮断薬、プロトンポンプ阻害剤、ACE阻害剤など）に、用途別には、皮膚生検、画像診断法、血液検査、心電図と心エコー図、肺機能検査にセグメント区分し、強皮症の診断および治療の世界市場を分析しました。

・エグゼクティブ・サマリー
・強皮症の診断および治療の世界市場概要
・強皮症の診断および治療の製造コスト構成分析
・強皮症の診断および治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・強皮症の診断および治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・強皮症の診断および治療のセグメント分析（種類別）
（コルチコステロイド、免疫抑制剤、エンドセリン受容体作動薬、カルシウムチャネル遮断薬、PDE-5阻害剤、キレート剤、プロスタサイクリンアナログ、その他（H2遮断薬、プロトンポンプ阻害剤、ACE阻害剤など））
・強皮症の診断および治療のセグメント分析（用途別）
（皮膚生検、画像診断法、血液検査、心電図と心エコー図、肺機能検査）
・強皮症の診断および治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Actelion Pharmaceuticals, Inc.、Boehringer Ingelheim、Bayer AG、Cytori Therapeutics, Inc.、Cumberland Pharmaceuticals Inc、Gilead Sciences, Inc.、Pfizer, Inc.、Sanofi、Corbus Pharmaceutical Holdings, Inc.、F. Hoffmann La Roche Ltd.、Merck KGaA、）
・強皮症の診断および治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Scleroderma Diagnostics and Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Scleroderma Diagnostics and Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Scleroderma Diagnostics and Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Scleroderma Diagnostics and Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Scleroderma Diagnostics and Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim
Bayer AG
Cytori Therapeutics, Inc.
Cumberland Pharmaceuticals Inc
Gilead Sciences, Inc.
Pfizer, Inc.
Sanofi
Corbus Pharmaceutical Holdings, Inc.
F. Hoffmann La Roche Ltd.
Merck KGaA

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Corticosteroids
Immunosuppressive Agents
Endothelin Receptor Agonists
Calcium Channel Blockers
PDE-5 Inhibitors
Chelating Agents
Prostacyclin Analogues
Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.)

Segment by Application
Skin Biopsy
Imaging Techniques
Blood Tests
Electrocardiogram and Echocardiogram
Pulmonary Function Tests

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Scleroderma Diagnostics and Therapeutics
1.1 Definition of Scleroderma Diagnostics and Therapeutics
1.2 Scleroderma Diagnostics and Therapeutics Segment by Type
1.2.1 Global Scleroderma Diagnostics and Therapeutics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Corticosteroids
1.2.3 Immunosuppressive Agents
1.2.4 Endothelin Receptor Agonists
1.2.5 Calcium Channel Blockers
1.2.6 PDE-5 Inhibitors
1.2.7 Chelating Agents
1.2.8 Prostacyclin Analogues
1.2.9 Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.)
1.3 Scleroderma Diagnostics and Therapeutics Segment by Applications
1.3.1 Global Scleroderma Diagnostics and Therapeutics Consumption Comparison by Applications (2014-2025)
1.3.2 Skin Biopsy
1.3.3 Imaging Techniques
1.3.4 Blood Tests
1.3.5 Electrocardiogram and Echocardiogram
1.3.6 Pulmonary Function Tests
1.4 Global Scleroderma Diagnostics and Therapeutics Overall Market
1.4.1 Global Scleroderma Diagnostics and Therapeutics Revenue (2014-2025)
1.4.2 Global Scleroderma Diagnostics and Therapeutics Production (2014-2025)
1.4.3 North America Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)
1.4.4 Europe Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)
1.4.5 China Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)
1.4.6 Japan Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)
1.4.8 India Scleroderma Diagnostics and Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Scleroderma Diagnostics and Therapeutics
2.3 Manufacturing Process Analysis of Scleroderma Diagnostics and Therapeutics
2.4 Industry Chain Structure of Scleroderma Diagnostics and Therapeutics

3 Development and Manufacturing Plants Analysis of Scleroderma Diagnostics and Therapeutics
3.1 Capacity and Commercial Production Date
3.2 Global Scleroderma Diagnostics and Therapeutics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Scleroderma Diagnostics and Therapeutics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Scleroderma Diagnostics and Therapeutics Production and Capacity Analysis
4.2 Scleroderma Diagnostics and Therapeutics Revenue Analysis
4.3 Scleroderma Diagnostics and Therapeutics Price Analysis
4.4 Market Concentration Degree

5 Scleroderma Diagnostics and Therapeutics Regional Market Analysis
5.1 Scleroderma Diagnostics and Therapeutics Production by Regions
5.1.1 Global Scleroderma Diagnostics and Therapeutics Production by Regions
5.1.2 Global Scleroderma Diagnostics and Therapeutics Revenue by Regions
5.2 Scleroderma Diagnostics and Therapeutics Consumption by Regions
5.3 North America Scleroderma Diagnostics and Therapeutics Market Analysis
5.3.1 North America Scleroderma Diagnostics and Therapeutics Production
5.3.2 North America Scleroderma Diagnostics and Therapeutics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Scleroderma Diagnostics and Therapeutics Import and Export
5.4 Europe Scleroderma Diagnostics and Therapeutics Market Analysis
5.4.1 Europe Scleroderma Diagnostics and Therapeutics Production
5.4.2 Europe Scleroderma Diagnostics and Therapeutics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Scleroderma Diagnostics and Therapeutics Import and Export
5.5 China Scleroderma Diagnostics and Therapeutics Market Analysis
5.5.1 China Scleroderma Diagnostics and Therapeutics Production
5.5.2 China Scleroderma Diagnostics and Therapeutics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Scleroderma Diagnostics and Therapeutics Import and Export
5.6 Japan Scleroderma Diagnostics and Therapeutics Market Analysis
5.6.1 Japan Scleroderma Diagnostics and Therapeutics Production
5.6.2 Japan Scleroderma Diagnostics and Therapeutics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Scleroderma Diagnostics and Therapeutics Import and Export
5.7 Southeast Asia Scleroderma Diagnostics and Therapeutics Market Analysis
5.7.1 Southeast Asia Scleroderma Diagnostics and Therapeutics Production
5.7.2 Southeast Asia Scleroderma Diagnostics and Therapeutics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Scleroderma Diagnostics and Therapeutics Import and Export
5.8 India Scleroderma Diagnostics and Therapeutics Market Analysis
5.8.1 India Scleroderma Diagnostics and Therapeutics Production
5.8.2 India Scleroderma Diagnostics and Therapeutics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Scleroderma Diagnostics and Therapeutics Import and Export

6 Scleroderma Diagnostics and Therapeutics Segment Market Analysis (by Type)
6.1 Global Scleroderma Diagnostics and Therapeutics Production by Type
6.2 Global Scleroderma Diagnostics and Therapeutics Revenue by Type
6.3 Scleroderma Diagnostics and Therapeutics Price by Type

7 Scleroderma Diagnostics and Therapeutics Segment Market Analysis (by Application)
7.1 Global Scleroderma Diagnostics and Therapeutics Consumption by Application
7.2 Global Scleroderma Diagnostics and Therapeutics Consumption Market Share by Application (2014-2019)

8 Scleroderma Diagnostics and Therapeutics Major Manufacturers Analysis
8.1 Actelion Pharmaceuticals, Inc.
8.1.1 Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.1.2 Actelion Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.2.2 Boehringer Ingelheim Product Introduction, Application and Specification
8.2.3 Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer AG
8.3.1 Bayer AG Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.3.2 Bayer AG Product Introduction, Application and Specification
8.3.3 Bayer AG Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cytori Therapeutics, Inc.
8.4.1 Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.4.2 Cytori Therapeutics, Inc. Product Introduction, Application and Specification
8.4.3 Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Cumberland Pharmaceuticals Inc
8.5.1 Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.5.2 Cumberland Pharmaceuticals Inc Product Introduction, Application and Specification
8.5.3 Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Gilead Sciences, Inc.
8.6.1 Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.6.2 Gilead Sciences, Inc. Product Introduction, Application and Specification
8.6.3 Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Pfizer, Inc.
8.7.1 Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.7.2 Pfizer, Inc. Product Introduction, Application and Specification
8.7.3 Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Sanofi
8.8.1 Sanofi Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.8.2 Sanofi Product Introduction, Application and Specification
8.8.3 Sanofi Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Corbus Pharmaceutical Holdings, Inc.
8.9.1 Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.9.2 Corbus Pharmaceutical Holdings, Inc. Product Introduction, Application and Specification
8.9.3 Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 F. Hoffmann La Roche Ltd.
8.10.1 F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
8.10.2 F. Hoffmann La Roche Ltd. Product Introduction, Application and Specification
8.10.3 F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Merck KGaA

9 Development Trend of Analysis of Scleroderma Diagnostics and Therapeutics Market
9.1 Global Scleroderma Diagnostics and Therapeutics Market Trend Analysis
9.1.1 Global Scleroderma Diagnostics and Therapeutics Market Size (Volume and Value) Forecast 2019-2025
9.2 Scleroderma Diagnostics and Therapeutics Regional Market Trend
9.2.1 North America Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.2.2 Europe Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.2.3 China Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.2.4 Japan Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.2.5 Southeast Asia Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.2.6 India Scleroderma Diagnostics and Therapeutics Forecast 2019-2025
9.3 Scleroderma Diagnostics and Therapeutics Market Trend (Product Type)
9.4 Scleroderma Diagnostics and Therapeutics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Scleroderma Diagnostics and Therapeutics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Scleroderma Diagnostics and Therapeutics
Table Global Scleroderma Diagnostics and Therapeutics Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Scleroderma Diagnostics and Therapeutics Production Market Share by Types in 2018
Figure Corticosteroids Product Picture
Figure Immunosuppressive Agents Product Picture
Figure Endothelin Receptor Agonists Product Picture
Figure Calcium Channel Blockers Product Picture
Figure PDE-5 Inhibitors Product Picture
Figure Chelating Agents Product Picture
Figure Prostacyclin Analogues Product Picture
Figure Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.) Product Picture
Table Global Scleroderma Diagnostics and Therapeutics Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Scleroderma Diagnostics and Therapeutics Consumption Market Share by Applications in 2018
Figure Skin Biopsy
Figure Imaging Techniques
Figure Blood Tests
Figure Electrocardiogram and Echocardiogram
Figure Pulmonary Function Tests
Figure Global Scleroderma Diagnostics and Therapeutics Revenue (Million USD) (2014-2025)
Figure Global Scleroderma Diagnostics and Therapeutics Production (K Units) (2014-2025)
Figure North America Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Figure Europe Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Figure China Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Figure Japan Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Figure India Scleroderma Diagnostics and Therapeutics Market Size (Million USD) (2014-2025)
Table Scleroderma Diagnostics and Therapeutics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Scleroderma Diagnostics and Therapeutics in 2018
Figure Manufacturing Process Analysis of Scleroderma Diagnostics and Therapeutics
Figure Industry Chain Structure of Scleroderma Diagnostics and Therapeutics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Scleroderma Diagnostics and Therapeutics Manufacturing Plants Distribution
Table Scleroderma Diagnostics and Therapeutics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Scleroderma Diagnostics and Therapeutics Capacity (K Units) of Major Manufacturers (2014-2019)
Table Scleroderma Diagnostics and Therapeutics Production (K Units) of Major Manufacturers (2014-2019)
Table Scleroderma Diagnostics and Therapeutics Production Market Share of Major Manufacturers (2014-2019)
Figure Scleroderma Diagnostics and Therapeutics Production Share by Manufacturers in 2018
Table Scleroderma Diagnostics and Therapeutics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Scleroderma Diagnostics and Therapeutics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Scleroderma Diagnostics and Therapeutics Revenue Share by Manufacturers in 2018
Table Scleroderma Diagnostics and Therapeutics Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Scleroderma Diagnostics and Therapeutics Production by Regions 2014-2019 (K Units)
Table Global Scleroderma Diagnostics and Therapeutics Production Market Share by Regions 2014-2019
Figure Global Scleroderma Diagnostics and Therapeutics Production Market Share by Regions in 2018
Table Global Scleroderma Diagnostics and Therapeutics Revenue by Regions 2014-2019 (Million USD)
Table Global Scleroderma Diagnostics and Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Scleroderma Diagnostics and Therapeutics Revenue Market Share by Regions in 2018
Table Global Scleroderma Diagnostics and Therapeutics Consumption by Regions 2014-2019 (K Units)
Table Global Scleroderma Diagnostics and Therapeutics Consumption Market Share by Regions 2014-2019
Figure North America Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure North America Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure Europe Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Europe Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure China Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure China Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table China Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure Japan Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Japan Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure Southeast Asia Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure India Scleroderma Diagnostics and Therapeutics Production Growth Rate 2014-2019 (K Units)
Figure India Scleroderma Diagnostics and Therapeutics Revenue Growth Rate 2014-2019 (Million USD)
Table India Scleroderma Diagnostics and Therapeutics Production, Consumption Import and Export (K Units)
Figure Global Consumption Scleroderma Diagnostics and Therapeutics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Scleroderma Diagnostics and Therapeutics Market Share by Application (2014-2019)
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Actelion Pharmaceuticals, Inc. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Boehringer Ingelheim Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Bayer AG Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Bayer AG Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Bayer AG Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer AG Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Bayer AG Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Bayer AG Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Bayer AG Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Cytori Therapeutics, Inc. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Cumberland Pharmaceuticals Inc Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Gilead Sciences, Inc. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Pfizer, Inc. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Sanofi Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Sanofi Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Sanofi Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Sanofi Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Sanofi Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Sanofi Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table Corbus Pharmaceutical Holdings, Inc. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Product Introduction, Application and Specification
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production Growth Rate (2014-2019)
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Production Market Share (2014-2019)
Figure F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Revenue Market Share (2014-2019)
Table F. Hoffmann La Roche Ltd. Scleroderma Diagnostics and Therapeutics Main Business and Markets Served
Table Merck KGaA Scleroderma Diagnostics and Therapeutics Production Sites and Area Served
Figure Global Scleroderma Diagnostics and Therapeutics Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Scleroderma Diagnostics and Therapeutics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Scleroderma Diagnostics and Therapeutics Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Scleroderma Diagnostics and Therapeutics Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Scleroderma Diagnostics and Therapeutics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Scleroderma Diagnostics and Therapeutics by Type (2019-2025)
Table Global Consumption (K Units) of Scleroderma Diagnostics and Therapeutics by Application (2019-2025)
Table Scleroderma Diagnostics and Therapeutics Distributors List
Table Scleroderma Diagnostics and Therapeutics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Actelion Pharmaceuticals, Inc.、Boehringer Ingelheim、Bayer AG、Cytori Therapeutics, Inc.、Cumberland Pharmaceuticals Inc、Gilead Sciences, Inc.、Pfizer, Inc.、Sanofi、Corbus Pharmaceutical Holdings, Inc.、F. Hoffmann La Roche Ltd.、Merck KGaA、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の強皮症の診断および治療市場(Global Scleroderma Diagnostics and Therapeutics Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp